New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

Ipamorelin

From $80.00

Shop

Ipamorelin · Research brief

What Does CJC-1295 DAC Do? A Deep Dive for Researchers

57 WORDS

Short answer

In the world of peptide research, stability is a constant battle. So many promising compounds have an incredibly short active life once introduced into a biological system, getting chewed up by enzymes in mere minutes. It’s a formidable challenge. This fleeting efficacy makes long-term studies difficult, often requiring frequent administration that can complicate protocols and muddy results.

In the world of peptide research, stability is a constant battle. So many promising compounds have an incredibly short active life once introduced into a biological system, getting chewed up by enzymes in mere minutes. It’s a formidable challenge. This fleeting efficacy makes long-term studies difficult, often requiring frequent administration that can complicate protocols and muddy results. Researchers are always on the hunt for more robust, long-acting analogs that can provide sustained effects, allowing for clearer observation over extended periods.

This is precisely where compounds like CJC-1295 with DAC enter the picture, representing a significant, sometimes dramatic shift in how we can approach certain research models. Here at Real Peptides, where our entire operation is built on the pillars of precision, purity, and reliability, we've seen immense interest in this particular molecule. So, let’s get straight to it. We’re going to break down exactly what CJC-1295 with DAC is, how that little three-letter acronym transforms its function, and what its unique mechanism means for the scientific community.

Understanding the Foundation: GHRH and the Pituitary Axis

Before we can really dig into what CJC-1295 DAC does, we have to talk about the body's natural system for regulating growth hormone (GH). It’s a beautifully complex and elegant system. The story starts in the hypothalamus with a peptide called Growth Hormone-Releasing Hormone, or GHRH. Think of GHRH as the primary 'on' switch for GH production.

When the body signals a need for growth hormone—for repair, metabolism, or growth—the hypothalamus releases GHRH. This hormone then travels a short distance to the anterior pituitary gland and binds to its specific receptors. This binding action is the signal the pituitary has been waiting for. It responds by synthesizing and releasing a pulse of growth hormone into the bloodstream.

It’s not a constant trickle, though. That’s the key. Natural GH release is pulsatile. It happens in waves, primarily during deep sleep and after intense exercise. This rhythmic ebb and flow is critical for its proper function and to prevent receptor desensitization. The problem, from a research perspective, is that natural GHRH itself has a half-life of only a few minutes before it's degraded by enzymes. This makes it a poor tool for studying the prolonged effects of GH elevation. Scientists needed something that could flip the 'on' switch and hold it down for a while longer. And that need is what drove the development of GHRH analogs.

What is CJC-1295? The Core Peptide Explained

At its heart, CJC-1295 is a synthetic analog of GHRH. It's a chain of 29 amino acids, just like a fragment of natural GHRH (specifically, the first 29 amino acids, which are the functionally active part). However, it's not an identical copy. Four of the amino acids in the chain have been strategically replaced with more stable ones. This modification, known as tetrasubstitution, makes the peptide chain itself more resistant to enzymatic degradation.

This base version of the molecule is what's often referred to as Mod GRF 1-29, or what we list on our site as CJC 1295 NO DAC.

It's a definite improvement over natural GHRH. Its structural changes give it a half-life of about 30 minutes instead of just 5-7 minutes. That’s a significant step up, allowing for a more pronounced and slightly longer GH pulse after administration in a research setting. But let's be honest, 30 minutes is still a very short window for many experimental models. Researchers needed more. They needed a way to keep the signal going not just for minutes, but for days. That's where the magic of 'DAC' comes in.

The Game-Changer: What Does the 'DAC' Part Do?

This is the core of the question. The 'DAC' stands for Drug Affinity Complex. It's not part of the peptide chain itself but is rather a small chemical group that is covalently bonded to the peptide, typically at the amino acid lysine.

So what does it do? Its function is brilliantly simple: it allows the CJC-1295 peptide to bind to albumin.

Albumin is the most abundant protein in blood plasma. It acts as a transport vehicle, carrying hormones, fatty acids, and various other compounds throughout the body. Our team often uses an analogy here: imagine the DAC as a tiny, powerful magnet attached to the CJC-1295 peptide. Once in the bloodstream, this magnet immediately latches onto the nearest massive cargo ship—albumin. By attaching to this large, stable protein, the CJC-1295 peptide is effectively shielded from the enzymes that would normally destroy it, particularly an enzyme called dipeptidyl peptidase-4 (DPP-IV).

This binding action is a complete game-changer for the peptide's pharmacokinetics. It extends the half-life of CJC-1295 from about 30 minutes to a staggering 6-8 days. It’s a massive leap. Instead of a brief signal to the pituitary, you now have a molecule that can circulate for over a week, continuously stimulating GHRH receptors. This is the fundamental answer to what does CJC-1295 DAC do: it transforms a short-acting GHRH analog into a long-acting one by giving it the ability to hitch a ride on albumin, protecting it from premature destruction.

CJC-1295 with DAC vs. Without DAC (Mod GRF 1-29)

To make the distinction crystal clear, our research team put together a simple comparison. Understanding these differences is absolutely critical for designing a valid study, as their application protocols are worlds apart.

Feature CJC-1295 with DAC CJC-1295 without DAC (Mod GRF 1-29)
Primary Mechanism Binds to albumin via DAC, providing a long-lasting GHRH signal. Tetrasubstituted GHRH analog with no albumin binding.
Half-Life Approximately 6-8 days. Approximately 30 minutes.
Effect on GH Creates a sustained elevation of baseline GH levels (a 'GH bleed'). Induces a short, strong pulse of GH release.
Research Dosing Freq. Infrequent (e.g., once or twice weekly). Frequent (e.g., multiple times per day).
Primary Use Case Long-term studies on sustained GH/IGF-1 elevation. Studies requiring distinct, timed GH pulses.
Synergy Pairs well with a GHRP for amplified pulses from a higher baseline. Often combined with a GHRP to maximize the size of each pulse.

This isn't a matter of one being 'better' than the other. They are simply different tools for different jobs. If a researcher wants to study the effects of a single, powerful GH spike, the 'no DAC' version is the appropriate instrument. But for investigating the downstream consequences of keeping GH and IGF-1 levels consistently elevated for a week or more, the DAC version is the only logical choice.

The Physiological Cascade: What Happens After Administration?

Now that we know the DAC allows the peptide to survive for days, what does this sustained signaling actually do within a biological system? The effects are multi-layered and fascinating to observe in a lab setting.

First, you get a sustained elevation of growth hormone. This is often referred to as a 'GH bleed'. Instead of sharp peaks returning to a low baseline, the DAC version elevates the entire baseline. The troughs between natural pulses are higher, meaning the system is consistently exposed to more GH around the clock. It's a fundamental shift in the body's GH environment.

Second, this constant GH signal tells the liver to ramp up its production of Insulin-like Growth Factor 1 (IGF-1). IGF-1 is a crucial hormone that mediates many of growth hormone's most well-known anabolic and restorative effects. Our experience shows that with CJC-1295 DAC, IGF-1 levels can become significantly and stably elevated, remaining high for the duration of the peptide's activity. This stable IGF-1 increase is a primary target for many researchers using this compound.

But here's a nuanced point that often gets missed: it preserves GH pulsatility. This is a critical, non-negotiable element of its function. Unlike administering synthetic growth hormone directly, which can shut down the body's natural production and flatten the pulsatile rhythm, CJC-1295 DAC doesn't do that. It simply elevates the floor from which the body's own natural GH pulses are launched. The pituitary can still release its own spikes on top of the elevated baseline created by the peptide. We can't stress this enough: this allows researchers to study elevated GH/IGF-1 levels within a more physiologically normal context, which is a massive advantage.

Key Areas of Research for CJC-1295 with DAC

The unique properties of CJC-1295 with DAC make it a valuable tool across a sprawling number of research fields. Its ability to create a stable, long-term elevation in GH and IGF-1 opens doors to studies that would be impractical with shorter-acting compounds.

One of the biggest areas is metabolic health. Growth hormone is a powerful metabolic agent, and its downstream partner, IGF-1, also plays a key role. Studies have investigated how sustained elevation of these hormones impacts lipolysis (the breakdown of stored fat for energy). By observing changes in body composition in animal models, scientists can better understand the intricate relationship between the GH axis and adipose tissue regulation. Some research even delves into its effects on glucose sensitivity and overall nutrient partitioning.

Cellular repair and recovery is another hotbed of investigation. GH and IGF-1 are fundamental to the body's repair processes. They are critical for stimulating collagen synthesis, which is vital for the health of skin, tendons, and ligaments. Researchers use compounds like CJC-1295 DAC to explore the potential for accelerating healing in models of tissue injury. It provides a way to study whether maintaining a pro-recovery hormonal environment can lead to faster and more robust tissue regeneration. This is an area where it might be studied alongside other fascinating molecules like the well-known BPC 157 Peptide, which works through entirely different pathways.

There's also a significant amount of research in the anti-aging and longevity space. It's well-documented that natural production of growth hormone declines significantly with age—a condition sometimes called somatopause. This decline is linked to many of the signs we associate with aging: loss of muscle mass, increased body fat, decreased bone density, and poorer recovery. CJC-1295 DAC provides researchers with an impeccable tool to study the effects of restoring GH and IGF-1 levels to more youthful ranges in aged models, helping to untangle which aspects of aging are directly influenced by this hormonal decline.

Synergies in Research: The Power of Combination

Now, this is where it gets really interesting for protocol design. CJC-1295 DAC is a GHRH analog. But there's another class of peptides called Growth Hormone Releasing Peptides, or GHRPs. These include compounds like Ipamorelin, GHRP-6, and GHRP-2.

They also stimulate the pituitary to release GH, but they do it through a completely different mechanism. They act on the ghrelin receptor, which is another pathway that triggers a GH pulse. What our team has found, and what is widely supported by literature, is that when you combine a GHRH analog with a GHRP, the resulting GH release isn't just additive—it's synergistic. The two signals together create a pulse of growth hormone that is far larger than what either compound could produce on its own.

This has led to the development of powerful research combinations. Pairing the long-acting CJC-1295 with DAC and a GHRP like Ipamorelin gives you the best of both worlds. The CJC-1295 DAC creates that high, stable baseline of GH, and then administering the Ipamorelin on top of that launches a massive, amplified pulse from that elevated starting point. For researchers looking to model both sustained elevation and powerful pulses, this combination is the gold standard. It’s why blended products like our CJC1295 Ipamorelin 5MG 5MG are so popular for advanced research applications.

The Real Peptides Difference: Why Purity is Everything

When you're working with a molecule as specific and complex as CJC-1295 with DAC, the quality of your material is paramount. We mean this sincerely: the integrity of your research depends entirely on the integrity of your starting materials. A peptide's function is dictated by its exact amino acid sequence and structure. Even a small error in synthesis, a missing DAC component, or the presence of contaminants can render your results completely invalid.

This is why at Real Peptides, we're unflinching in our commitment to quality. We specialize in small-batch synthesis, which gives us meticulous control over every step of the process. This ensures that the amino-acid sequencing is perfect and that the final lyophilized product achieves the highest possible purity. It’s a non-negotiable standard for us because we know that researchers stake their time, funding, and reputations on the validity of their data. A contaminated or incorrectly synthesized peptide isn't just unhelpful; it's a catastrophic point of failure for an experiment.

This dedication is why so many labs trust us to Find the Right Peptide Tools for Your Lab. They know that when they receive a vial from us, they are getting exactly what's on the label, synthesized with the precision required for cutting-edge biological research. From the peptide itself to the sterile Bacteriostatic Water needed for reconstitution, every component matters.

CJC-1295 with DAC is a testament to the ingenuity of peptide engineering. It’s a sophisticated tool that solves a very real problem for researchers: the need for a stable, long-acting GHRH signal. By understanding its unique albumin-binding mechanism, scientists can design more effective, long-term studies to explore the sprawling roles of the GH/IGF-1 axis in health, metabolism, and aging. The possibilities are immense, and as research continues to push boundaries, having reliable, high-purity compounds is more critical than ever. We're here to support that journey and invite you to Explore High-Purity Research Peptides to equip your lab with the quality it deserves.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

The key difference is the half-life. The DAC (Drug Affinity Complex) allows the peptide to bind to albumin in the blood, extending its half-life from about 30 minutes to 6-8 days. This changes its research application from inducing short pulses to creating sustained GH elevation.
The DAC is a chemical moiety attached to the peptide that has a high affinity for albumin, a major protein in blood plasma. This binding protects the peptide from rapid enzymatic degradation, allowing it to circulate and remain active for a much longer period.
CJC-1295 DAC is a GHRH (Growth Hormone-Releasing Hormone) analog. It works by stimulating the GHRH receptors in the pituitary gland, which is the primary natural pathway for signaling growth hormone release.
‘GH bleed’ refers to the effect of CJC-1295 with DAC creating a continuous, low-level release of growth hormone. This elevates the baseline or ‘trough’ levels of GH in between the body’s natural pulses, rather than causing a single large spike.
Albumin binding is the entire reason for its long-acting nature. By attaching to this large, stable protein, CJC-1295 DAC is shielded from enzymes that would otherwise break it down in minutes, drastically extending its therapeutic and research potential.
Due to its strong albumin binding, CJC-1295 with DAC has a half-life of approximately 6 to 8 days. This means it can continue to stimulate GH release for over a week after a single administration in a research setting.
Absolutely. It is very commonly studied in combination with GHRPs (Growth Hormone Releasing Peptides) like Ipamorelin. This creates a synergistic effect, producing a much more robust GH pulse than either compound could alone.
No, and this is a key benefit. It elevates the baseline GH levels but does not suppress the natural, pulsatile release from the pituitary gland. The body’s own pulses are simply launched from a higher starting point.
Purity is non-negotiable because any contaminants or errors in the amino acid sequence can alter the peptide’s function or produce confounding results. For reliable, reproducible data, researchers must start with a compound of the highest possible purity.
Both are GHRH analogs, but they differ in structure and application. Tesamorelin is a 44-amino acid analog approved for specific medical uses, while CJC-1295 DAC is a modified 29-amino acid peptide designed specifically for an extended half-life via DAC technology for research purposes.
Indirectly, yes. CJC-1295 DAC stimulates the pituitary to release more growth hormone. This sustained increase in GH then signals the liver to produce and release more IGF-1, which is a primary mediator of many of GH’s effects.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now